###begin article-title 0
###xml 55 58 55 58 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GCK</italic>
###xml 60 64 60 64 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GCKR</italic>
###xml 66 71 66 71 <italic xmlns:xlink="http://www.w3.org/1999/xlink">G6PC2</italic>
###xml 76 82 76 82 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MTNR1B</italic>
Combined effects of single-nucleotide polymorphisms in GCK, GCKR, G6PC2 and MTNR1B on fasting plasma glucose and type 2 diabetes risk
###end article-title 0
###begin title 1
Aims/hypothesis
###end title 1
###begin p 2
###xml 209 212 209 212 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GCK</italic>
###xml 247 251 247 251 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GCKR</italic>
###xml 326 331 326 331 <italic xmlns:xlink="http://www.w3.org/1999/xlink">G6PC2</italic>
###xml 365 371 365 371 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MTNR1B</italic>
Variation in fasting plasma glucose (FPG) within the normal range is a known risk factor for the development of type 2 diabetes. Several reports have shown that genetic variation in the genes for glucokinase (GCK), glucokinase regulatory protein (GCKR), islet-specific glucose 6 phosphatase catalytic subunit-related protein (G6PC2) and melatonin receptor type 1B (MTNR1B) is associated with FPG. In this study we examined whether these loci also contribute to type 2 diabetes susceptibility.
###end p 2
###begin title 3
Methods
###end title 3
###begin p 4
###xml 123 135 <span type="species:ncbi:9606">participants</span>
###xml 212 224 <span type="species:ncbi:9606">participants</span>
A random selection from the Dutch New Hoorn Study was used for replication of the association with FGP (2,361 non-diabetic participants). For the genetic association study we extended the study sample with 2,628 participants with type 2 diabetes. Risk allele counting was used to calculate a four-gene risk allele score for each individual.
###end p 4
###begin title 5
Results
###end title 5
###begin p 6
###xml 16 19 16 19 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GCK</italic>
###xml 21 26 21 26 <italic xmlns:xlink="http://www.w3.org/1999/xlink">G6PC2</italic>
###xml 31 37 31 37 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MTNR1B</italic>
###xml 52 56 52 56 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GCKR</italic>
###xml 88 89 88 89 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 101 105 99 103 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GCKR</italic>
###xml 107 108 105 106 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 247 248 245 246 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 257 260 255 258 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;13</sup>
###xml 484 485 482 483 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 519 520 517 518 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 529 531 527 529 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;6</sup>
###xml 635 636 633 634 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 276 288 <span type="species:ncbi:9606">participants</span>
Variants of the GCK, G6PC2 and MTNR1B genes but not GCKR were associated with FPG (all, p </= 0.001; GCKR, p = 0.23). Combining these four genes in a risk allele score resulted in an increase of 0.05 mmol/l (0.04-0.07) per additional risk allele (p = 2 x 10-13). Furthermore, participants with less than three or more than five risk alleles showed significantly different type 2 diabetes susceptibility compared with the most common group with four risk alleles (OR 0.77 [0.65-0.93], p = 0.005 and OR 2.05 [1.50-2.80], p = 4 x 10-6 respectively). The age at diagnosis was also significantly associated with the number of risk alleles (p = 0.009).
###end p 6
###begin title 7
Conclusions
###end title 7
###begin p 8
###xml 132 134 132 134 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1c</sub>
###xml 186 198 <span type="species:ncbi:9606">participants</span>
A combined risk allele score for single-nucleotide polymorphisms in four known FPG loci is significantly associated with FPG and HbA1c in a Dutch population-based sample of non-diabetic participants. Carriers of low or high numbers of risk alleles show significantly different risks for type 2 diabetes compared with the reference group.
###end p 8
###begin title 9
Electronic supplementary material
###end title 9
###begin p 10
The online version of this article (doi:10.1007/s00125-009-1413-9) contains supplementary material, which is available to authorised users.
###end p 10
###begin title 11
Keywords
###end title 11
###begin title 12
Introduction
###end title 12
###begin p 13
###xml 169 170 169 170 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR1">1</xref>
###xml 172 173 172 173 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR2">2</xref>
###xml 247 248 247 248 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR3">3</xref>
###xml 340 343 340 343 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GCK</italic>
###xml 378 382 378 382 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GCKR</italic>
###xml 460 465 460 465 <italic xmlns:xlink="http://www.w3.org/1999/xlink">G6PC2</italic>
###xml 468 469 468 469 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR4">4</xref>
###xml 470 472 470 472 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR10">10</xref>
###xml 531 537 531 537 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MTNR1B</italic>
###xml 589 591 589 591 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR11">11</xref>
###xml 592 594 592 594 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR13">13</xref>
Variation in fasting plasma glucose (FPG) levels within the normal range are associated with an increased risk of developing type 2 diabetes and coronary heart disease [1, 2]. Furthermore, it is known that FPG is partially genetically determined [3]. Several loci influencing FPG levels have been identified. These loci encode glucokinase (GCK), glucokinase regulatory protein (GCKR) and islet-specific glucose 6 phosphatase catalytic subunit-related protein (G6PC2) [4-10]. Recently, the gene encoding melatonin receptor type 1B (MTNR1B) was identified as a fourth locus influencing FPG [11-13]. In this study we investigated the combined effect of these loci on FPG levels in the Netherlands and analysed their single and combined effects on the risk of type 2 diabetes.
###end p 13
###begin title 14
Methods
###end title 14
###begin title 15
Study samples
###end title 15
###begin p 16
###xml 0 42 0 42 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Study sample for continuous trait analysis</bold>
###xml 261 263 261 263 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR14">14</xref>
###xml 265 267 265 267 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR15">15</xref>
###xml 547 549 545 547 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR16">16</xref>
###xml 78 90 <span type="species:ncbi:9606">participants</span>
###xml 312 324 <span type="species:ncbi:9606">participants</span>
Study sample for continuous trait analysis For this part of the study we used participants from the ongoing New Hoorn Study, a population-based cohort study in the Netherlands, which examines potential determinants of glucose intolerance and related disorders [14, 15]. From this study, 2,361 non-diabetic white participants (46% male, aged 53 +/- 7 years) were selected from the original random sample of the population register of the town of Hoorn, the Netherlands. Glucose tolerance status was assessed with OGTTs using the 1999 WHO criteria [16].
###end p 16
###begin p 17
###xml 0 64 0 64 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Case&#8211;control sample for genetic association with type 2 diabetes</bold>
###xml 173 174 173 174 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 270 271 270 271 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 410 411 410 411 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 440 441 440 441 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 559 560 559 560 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 571 573 571 573 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR17">17</xref>
###xml 97 109 <span type="species:ncbi:9606">participants</span>
###xml 698 706 <span type="species:ncbi:9606">patients</span>
###xml 727 734 <span type="species:ncbi:9606">patient</span>
###xml 748 756 <span type="species:ncbi:9606">Patients</span>
###xml 925 933 <span type="species:ncbi:9606">patients</span>
###xml 1165 1177 <span type="species:ncbi:9606">participants</span>
###xml 1265 1277 <span type="species:ncbi:9606">participants</span>
Case-control sample for genetic association with type 2 diabetes As a control sample we used all participants with normal glucose tolerance from the above-mentioned sample (n = 2,041). Subjects with impaired glucose tolerance (IGT) and/or impaired fasting glucose (IFG; n = 320) were excluded from the control group because they have an increased risk of type 2 diabetes.For the case sample we used all known (n = 90) and newly identified (n = 90) cases from the New Hoorn Study. To improve power we added cases from Diabetes Care System West Friesland (DCS, n = 1,906) [17]. The DCS aims to improve diabetes care by coordinating diabetes care, involving all caregivers and providing education for patients in order to improve patient empowerment. Patients are referred to the DCS by their physicians and are from the same geographical region as those taking part in the New Hoorn Study. We also included 542 type 2 diabetes patients from the diabetes clinics at Leiden University Medical Centre (Leiden, the Netherlands) and VU University Medical Centre (Amsterdam, the Netherlands), who were referred to the clinic by their physicians. In total we selected 2,628 participants with type 2 diabetes (55% males, aged 64 +/- 11 years) for the case-control study. All participants in our study were of white ethnicity. The study was approved by the appropriate medical ethics committees and was in accordance with the principles of the Declaration of Helsinki.
###end p 17
###begin title 18
Genotyping and quality control
###end title 18
###begin p 19
###xml 100 103 100 103 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GCK</italic>
###xml 105 106 105 106 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR4">4</xref>
###xml 130 134 130 134 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GCKR</italic>
###xml 136 137 136 137 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR7">7</xref>
###xml 152 157 152 157 <italic xmlns:xlink="http://www.w3.org/1999/xlink">G6PC2</italic>
###xml 159 160 159 160 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR9">9</xref>
###xml 180 186 180 186 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MTNR1B</italic>
###xml 188 190 188 190 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR11">11</xref>
###xml 191 193 191 193 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR13">13</xref>
###xml 566 567 566 567 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
Based on previous publications, we selected the single-nucleotide polymorphisms (SNPs) rs1799884 in GCK [4], rs1260326 (P446L) in GCKR [7], rs560887 in G6PC2 [9] and rs10830963 in MTNR1B [11-13] for genotyping with Taqman SNP genotyping assay (Applied Biosystems, Foster City, CA, USA). All genotype frequencies were similar between the case subgroups. For quality control the allelic discrimination plots were visually observed for good clustering. Plates with bad clustering or a success rate below 95% were repeated. Next, we assessed Hardy-Weinberg equilibrium (p > 0.05) and genotyped approximately 5% duplicate samples, which all showed identical genotypes.
###end p 19
###begin title 20
Statistical analysis
###end title 20
###begin p 21
###xml 52 54 52 54 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1c</sub>
###xml 481 483 481 483 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR18">18</xref>
###xml 1039 1040 1039 1040 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 1182 1183 1182 1183 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 170 182 <span type="species:ncbi:9606">participants</span>
###xml 676 688 <span type="species:ncbi:9606">participants</span>
Differences in FPG and other clinical variables (HbA1c, 2 h glucose, triacylglycerol, LDL, HDL, total cholesterol, BMI and waist-hip ratio) were analysed in non-diabetic participants using linear regression, adjusted for BMI, age and sex as possible confounders. All analyses were performed using an additive model, because previous studies had shown that this model was the best fit. In order to combine the effects of all SNPs, risk alleles were counted and used as a sum score [18]. A risk allele was defined as an allele that results in an increased FPG as described in the literature. Differences in genotype distribution, allele frequency and risk allele scores between participants with normal glucose tolerance and those with type 2 diabetes were compared using standard contingency tables with Fisher's exact test, and allelic ORs were calculated with logistic regression adjusted for age, sex and BMI. Subjects with either IGT or IFG were excluded from this analysis. Using Bonferroni correction for multiple hypothesis testing, p < 0.001 was considered statistically significant for association of FPG loci with clinical variables (36 tests). For the case-control study, p < 0.01 was considered significant (four tests). All statistics were calculated using SPSS 16.0 (SPSS, Chicago, IL, USA).
###end p 21
###begin title 22
Power calculations
###end title 22
###begin p 23
###xml 48 50 48 50 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR19">19</xref>
###xml 209 214 209 210 <italic xmlns:xlink="http://www.w3.org/1999/xlink">&#945;</italic>
###xml 375 380 371 372 <italic xmlns:xlink="http://www.w3.org/1999/xlink">&#945;</italic>
Power calculations were performed using Quanto [19]. We had an estimated power of 80% to detect a minimal per allele effect in clinical variables between 0.056 and 0.069 mmol/l, depending on allele frequency (alpha = 0.001). For the association study with type 2 diabetes we had an estimated power of 80% to detect a minimal OR between 1.13 and 1.16 for single gene effects (alpha = 0.01). For all power calculations we assumed an additive model.
###end p 23
###begin title 24
Results
###end title 24
###begin p 25
###xml 242 243 242 243 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 267 271 265 269 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GCKR</italic>
###xml 339 340 337 338 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 372 373 370 371 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Tab1" ref-type="table">1</xref>
###xml 385 389 383 387 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GCKR</italic>
###xml 482 483 480 481 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 491 492 489 490 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 552 553 550 551 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="MOESM1">1</xref>
###xml 569 572 567 570 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GCK</italic>
###xml 577 582 575 580 <italic xmlns:xlink="http://www.w3.org/1999/xlink">G6PC2</italic>
###xml 603 605 601 603 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1c</sub>
###xml 614 615 612 613 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 624 626 622 624 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;8</sup>
###xml 637 639 635 637 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;5</sup>
###xml 651 652 649 650 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="MOESM1">1</xref>
###xml 685 689 683 687 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GCKR</italic>
###xml 717 719 715 717 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1c</sub>
###xml 728 729 726 727 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 829 833 827 831 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GCKR</italic>
###xml 874 875 872 873 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 884 886 882 884 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;7</sup>
###xml 898 899 896 897 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="MOESM1">1</xref>
###xml 902 903 900 901 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR5">5</xref>
###xml 996 997 994 995 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="MOESM1">1</xref>
###xml 1249 1250 1247 1248 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 1259 1262 1257 1260 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;13</sup>
###xml 1269 1271 1267 1269 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Fig1" ref-type="fig">1a</xref>
###xml 1311 1313 1309 1311 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1c</sub>
###xml 1371 1372 1369 1370 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 1381 1384 1379 1382 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;10</sup>
###xml 1391 1393 1389 1391 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Fig1" ref-type="fig">1b</xref>
###xml 1650 1651 1648 1649 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="MOESM3">1</xref>
###xml 1728 1729 1726 1727 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 1790 1797 1788 1795 <label xmlns:xlink="http://www.w3.org/1999/xlink">Table&#160;1</label>
###xml 1827 1828 1825 1826 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 1859 1860 1857 1858 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 1797 1869 1795 1867 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="26">Association of SNPs with FPG (<italic>n</italic>&#8201;=&#8201;2,361) and type 2 diabetes (<italic>n</italic>&#8201;=&#8201;4,669)</p>
###xml 1797 1869 1795 1867 <caption xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="26">Association of SNPs with FPG (<italic>n</italic>&#8201;=&#8201;2,361) and type 2 diabetes (<italic>n</italic>&#8201;=&#8201;4,669)</p></caption>
###xml 1869 1872 1867 1870 <th xmlns:xlink="http://www.w3.org/1999/xlink" rowspan="2">SNP</th>
###xml 1872 1877 1870 1875 <th xmlns:xlink="http://www.w3.org/1999/xlink" rowspan="2">Locus</th>
###xml 1877 1888 1875 1886 <th xmlns:xlink="http://www.w3.org/1999/xlink" rowspan="2">Risk allele</th>
###xml 1888 1916 1886 1914 <th xmlns:xlink="http://www.w3.org/1999/xlink" colspan="3">FPG, mmol/l (genotype count)</th>
###xml 1916 1950 1914 1948 <th xmlns:xlink="http://www.w3.org/1999/xlink" rowspan="2">Effect per allele, mmol/l (95% CI)</th>
###xml 1950 1951 1948 1949 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 1950 1957 1948 1955 <th xmlns:xlink="http://www.w3.org/1999/xlink" rowspan="2"><italic>p</italic> value</th>
###xml 1957 1963 1955 1961 <th xmlns:xlink="http://www.w3.org/1999/xlink">T2D OR</th>
###xml 1963 1964 1961 1962 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 1963 1970 1961 1968 <th xmlns:xlink="http://www.w3.org/1999/xlink" rowspan="2"><italic>p</italic> value</th>
###xml 1869 1970 1867 1968 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><th rowspan="2">SNP</th><th rowspan="2">Locus</th><th rowspan="2">Risk allele</th><th colspan="3">FPG, mmol/l (genotype count)</th><th rowspan="2">Effect per allele, mmol/l (95% CI)</th><th rowspan="2"><italic>p</italic> value</th><th>T2D OR</th><th rowspan="2"><italic>p</italic> value</th></tr>
###xml 1970 1972 1968 1970 <th xmlns:xlink="http://www.w3.org/1999/xlink">AA</th>
###xml 1972 1974 1970 1972 <th xmlns:xlink="http://www.w3.org/1999/xlink">AB</th>
###xml 1974 1976 1972 1974 <th xmlns:xlink="http://www.w3.org/1999/xlink">BB</th>
###xml 1976 1982 1974 1980 <th xmlns:xlink="http://www.w3.org/1999/xlink">95% CI</th>
###xml 1970 1982 1968 1980 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><th>AA</th><th>AB</th><th>BB</th><th>95% CI</th></tr>
###xml 1869 1982 1867 1980 <thead xmlns:xlink="http://www.w3.org/1999/xlink"><tr><th rowspan="2">SNP</th><th rowspan="2">Locus</th><th rowspan="2">Risk allele</th><th colspan="3">FPG, mmol/l (genotype count)</th><th rowspan="2">Effect per allele, mmol/l (95% CI)</th><th rowspan="2"><italic>p</italic> value</th><th>T2D OR</th><th rowspan="2"><italic>p</italic> value</th></tr><tr><th>AA</th><th>AB</th><th>BB</th><th>95% CI</th></tr></thead>
###xml 1982 1991 1980 1989 <td xmlns:xlink="http://www.w3.org/1999/xlink">rs1799884</td>
###xml 1991 1994 1989 1992 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GCK</italic>
###xml 1991 1994 1989 1992 <td xmlns:xlink="http://www.w3.org/1999/xlink"><italic>GCK</italic></td>
###xml 1994 1995 1992 1993 <td xmlns:xlink="http://www.w3.org/1999/xlink">A</td>
###xml 1995 2016 1993 2012 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">5.39&#8201;&#177;&#8201;0.01 (1,523)</td>
###xml 2016 2035 2012 2029 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">5.45&#8201;&#177;&#8201;0.02 (620)</td>
###xml 2035 2053 2029 2045 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">5.47&#8201;&#177;&#8201;0.05 (65)</td>
###xml 2053 2070 2045 2062 <td xmlns:xlink="http://www.w3.org/1999/xlink">0.06 (0.03, 0.09)</td>
###xml 2070 2075 2062 2067 <td xmlns:xlink="http://www.w3.org/1999/xlink">0.001</td>
###xml 2075 2092 2067 2084 <td xmlns:xlink="http://www.w3.org/1999/xlink">1.12 (1.00, 1.25)</td>
###xml 2092 2096 2084 2088 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">0.06</td>
###xml 1982 2096 1980 2088 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td>rs1799884</td><td><italic>GCK</italic></td><td>A</td><td char="(" align="char">5.39&#8201;&#177;&#8201;0.01 (1,523)</td><td char="(" align="char">5.45&#8201;&#177;&#8201;0.02 (620)</td><td char="(" align="char">5.47&#8201;&#177;&#8201;0.05 (65)</td><td>0.06 (0.03, 0.09)</td><td>0.001</td><td>1.12 (1.00, 1.25)</td><td char="." align="char">0.06</td></tr>
###xml 2096 2105 2088 2097 <td xmlns:xlink="http://www.w3.org/1999/xlink">rs1260326</td>
###xml 2105 2109 2097 2101 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GCKR</italic>
###xml 2105 2109 2097 2101 <td xmlns:xlink="http://www.w3.org/1999/xlink"><italic>GCKR</italic></td>
###xml 2109 2110 2101 2102 <td xmlns:xlink="http://www.w3.org/1999/xlink">C</td>
###xml 2110 2129 2102 2119 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">5.35&#8201;&#177;&#8201;0.03 (267)</td>
###xml 2129 2148 2119 2136 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">5.39&#8201;&#177;&#8201;0.01 (956)</td>
###xml 2148 2167 2136 2153 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">5.38&#8201;&#177;&#8201;0.01 (924)</td>
###xml 2167 2185 2153 2171 <td xmlns:xlink="http://www.w3.org/1999/xlink">0.01 (&#8722;0.02, 0.03)</td>
###xml 2185 2189 2171 2175 <td xmlns:xlink="http://www.w3.org/1999/xlink">0.23</td>
###xml 2189 2206 2175 2192 <td xmlns:xlink="http://www.w3.org/1999/xlink">0.94 (0.86, 1.02)</td>
###xml 2206 2210 2192 2196 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">0.13</td>
###xml 2096 2210 2088 2196 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td>rs1260326</td><td><italic>GCKR</italic></td><td>C</td><td char="(" align="char">5.35&#8201;&#177;&#8201;0.03 (267)</td><td char="(" align="char">5.39&#8201;&#177;&#8201;0.01 (956)</td><td char="(" align="char">5.38&#8201;&#177;&#8201;0.01 (924)</td><td>0.01 (&#8722;0.02, 0.03)</td><td>0.23</td><td>0.94 (0.86, 1.02)</td><td char="." align="char">0.13</td></tr>
###xml 2210 2218 2196 2204 <td xmlns:xlink="http://www.w3.org/1999/xlink">rs560887</td>
###xml 2218 2223 2204 2209 <italic xmlns:xlink="http://www.w3.org/1999/xlink">G6PC2</italic>
###xml 2218 2223 2204 2209 <td xmlns:xlink="http://www.w3.org/1999/xlink"><italic>G6PC2</italic></td>
###xml 2223 2224 2209 2210 <td xmlns:xlink="http://www.w3.org/1999/xlink">G</td>
###xml 2224 2243 2210 2227 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">5.32&#8201;&#177;&#8201;0.03 (218)</td>
###xml 2243 2262 2227 2244 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">5.36&#8201;&#177;&#8201;0.01 (930)</td>
###xml 2262 2283 2244 2263 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">5.43&#8201;&#177;&#8201;0.01 (1,077)</td>
###xml 2283 2300 2263 2280 <td xmlns:xlink="http://www.w3.org/1999/xlink">0.06 (0.04, 0.09)</td>
###xml 2306 2308 2286 2288 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;6</sup>
###xml 2300 2308 2280 2288 <td xmlns:xlink="http://www.w3.org/1999/xlink">5&#8201;&#215;&#8201;10<sup>&#8722;6</sup></td>
###xml 2308 2325 2288 2305 <td xmlns:xlink="http://www.w3.org/1999/xlink">0.96 (0.87, 1.05)</td>
###xml 2325 2329 2305 2309 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">0.32</td>
###xml 2210 2329 2196 2309 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td>rs560887</td><td><italic>G6PC2</italic></td><td>G</td><td char="(" align="char">5.32&#8201;&#177;&#8201;0.03 (218)</td><td char="(" align="char">5.36&#8201;&#177;&#8201;0.01 (930)</td><td char="(" align="char">5.43&#8201;&#177;&#8201;0.01 (1,077)</td><td>0.06 (0.04, 0.09)</td><td>5&#8201;&#215;&#8201;10<sup>&#8722;6</sup></td><td>0.96 (0.87, 1.05)</td><td char="." align="char">0.32</td></tr>
###xml 2329 2339 2309 2319 <td xmlns:xlink="http://www.w3.org/1999/xlink">rs10830963</td>
###xml 2339 2345 2319 2325 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MTNR1B</italic>
###xml 2339 2345 2319 2325 <td xmlns:xlink="http://www.w3.org/1999/xlink"><italic>MTNR1B</italic></td>
###xml 2345 2346 2325 2326 <td xmlns:xlink="http://www.w3.org/1999/xlink">G</td>
###xml 2346 2367 2326 2345 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">5.37&#8201;&#177;&#8201;0.01 (1,269)</td>
###xml 2367 2386 2345 2362 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">5.44&#8201;&#177;&#8201;0.01 (891)</td>
###xml 2386 2405 2362 2379 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">5.52&#8201;&#177;&#8201;0.04 (135)</td>
###xml 2405 2422 2379 2396 <td xmlns:xlink="http://www.w3.org/1999/xlink">0.08 (0.05, 0.11)</td>
###xml 2428 2430 2402 2404 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;8</sup>
###xml 2422 2430 2396 2404 <td xmlns:xlink="http://www.w3.org/1999/xlink">7&#8201;&#215;&#8201;10<sup>&#8722;8</sup></td>
###xml 2430 2447 2404 2421 <td xmlns:xlink="http://www.w3.org/1999/xlink">1.12 (1.02, 1.23)</td>
###xml 2447 2451 2421 2425 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">0.02</td>
###xml 2329 2451 2309 2425 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td>rs10830963</td><td><italic>MTNR1B</italic></td><td>G</td><td char="(" align="char">5.37&#8201;&#177;&#8201;0.01 (1,269)</td><td char="(" align="char">5.44&#8201;&#177;&#8201;0.01 (891)</td><td char="(" align="char">5.52&#8201;&#177;&#8201;0.04 (135)</td><td>0.08 (0.05, 0.11)</td><td>7&#8201;&#215;&#8201;10<sup>&#8722;8</sup></td><td>1.12 (1.02, 1.23)</td><td char="." align="char">0.02</td></tr>
###xml 1982 2451 1980 2425 <tbody xmlns:xlink="http://www.w3.org/1999/xlink"><tr><td>rs1799884</td><td><italic>GCK</italic></td><td>A</td><td char="(" align="char">5.39&#8201;&#177;&#8201;0.01 (1,523)</td><td char="(" align="char">5.45&#8201;&#177;&#8201;0.02 (620)</td><td char="(" align="char">5.47&#8201;&#177;&#8201;0.05 (65)</td><td>0.06 (0.03, 0.09)</td><td>0.001</td><td>1.12 (1.00, 1.25)</td><td char="." align="char">0.06</td></tr><tr><td>rs1260326</td><td><italic>GCKR</italic></td><td>C</td><td char="(" align="char">5.35&#8201;&#177;&#8201;0.03 (267)</td><td char="(" align="char">5.39&#8201;&#177;&#8201;0.01 (956)</td><td char="(" align="char">5.38&#8201;&#177;&#8201;0.01 (924)</td><td>0.01 (&#8722;0.02, 0.03)</td><td>0.23</td><td>0.94 (0.86, 1.02)</td><td char="." align="char">0.13</td></tr><tr><td>rs560887</td><td><italic>G6PC2</italic></td><td>G</td><td char="(" align="char">5.32&#8201;&#177;&#8201;0.03 (218)</td><td char="(" align="char">5.36&#8201;&#177;&#8201;0.01 (930)</td><td char="(" align="char">5.43&#8201;&#177;&#8201;0.01 (1,077)</td><td>0.06 (0.04, 0.09)</td><td>5&#8201;&#215;&#8201;10<sup>&#8722;6</sup></td><td>0.96 (0.87, 1.05)</td><td char="." align="char">0.32</td></tr><tr><td>rs10830963</td><td><italic>MTNR1B</italic></td><td>G</td><td char="(" align="char">5.37&#8201;&#177;&#8201;0.01 (1,269)</td><td char="(" align="char">5.44&#8201;&#177;&#8201;0.01 (891)</td><td char="(" align="char">5.52&#8201;&#177;&#8201;0.04 (135)</td><td>0.08 (0.05, 0.11)</td><td>7&#8201;&#215;&#8201;10<sup>&#8722;8</sup></td><td>1.12 (1.02, 1.23)</td><td char="." align="char">0.02</td></tr></tbody>
###xml 1869 2451 1867 2425 <table xmlns:xlink="http://www.w3.org/1999/xlink" frame="hsides" rules="groups"><thead><tr><th rowspan="2">SNP</th><th rowspan="2">Locus</th><th rowspan="2">Risk allele</th><th colspan="3">FPG, mmol/l (genotype count)</th><th rowspan="2">Effect per allele, mmol/l (95% CI)</th><th rowspan="2"><italic>p</italic> value</th><th>T2D OR</th><th rowspan="2"><italic>p</italic> value</th></tr><tr><th>AA</th><th>AB</th><th>BB</th><th>95% CI</th></tr></thead><tbody><tr><td>rs1799884</td><td><italic>GCK</italic></td><td>A</td><td char="(" align="char">5.39&#8201;&#177;&#8201;0.01 (1,523)</td><td char="(" align="char">5.45&#8201;&#177;&#8201;0.02 (620)</td><td char="(" align="char">5.47&#8201;&#177;&#8201;0.05 (65)</td><td>0.06 (0.03, 0.09)</td><td>0.001</td><td>1.12 (1.00, 1.25)</td><td char="." align="char">0.06</td></tr><tr><td>rs1260326</td><td><italic>GCKR</italic></td><td>C</td><td char="(" align="char">5.35&#8201;&#177;&#8201;0.03 (267)</td><td char="(" align="char">5.39&#8201;&#177;&#8201;0.01 (956)</td><td char="(" align="char">5.38&#8201;&#177;&#8201;0.01 (924)</td><td>0.01 (&#8722;0.02, 0.03)</td><td>0.23</td><td>0.94 (0.86, 1.02)</td><td char="." align="char">0.13</td></tr><tr><td>rs560887</td><td><italic>G6PC2</italic></td><td>G</td><td char="(" align="char">5.32&#8201;&#177;&#8201;0.03 (218)</td><td char="(" align="char">5.36&#8201;&#177;&#8201;0.01 (930)</td><td char="(" align="char">5.43&#8201;&#177;&#8201;0.01 (1,077)</td><td>0.06 (0.04, 0.09)</td><td>5&#8201;&#215;&#8201;10<sup>&#8722;6</sup></td><td>0.96 (0.87, 1.05)</td><td char="." align="char">0.32</td></tr><tr><td>rs10830963</td><td><italic>MTNR1B</italic></td><td>G</td><td char="(" align="char">5.37&#8201;&#177;&#8201;0.01 (1,269)</td><td char="(" align="char">5.44&#8201;&#177;&#8201;0.01 (891)</td><td char="(" align="char">5.52&#8201;&#177;&#8201;0.04 (135)</td><td>0.08 (0.05, 0.11)</td><td>7&#8201;&#215;&#8201;10<sup>&#8722;8</sup></td><td>1.12 (1.02, 1.23)</td><td char="." align="char">0.02</td></tr></tbody></table>
###xml 2451 2532 2425 2504 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="27">Estimated FPG levels (mean&#8201;&#177;&#8201;SD) per genotype are adjusted for age, sex and BMI</p>
###xml 2568 2569 2540 2541 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 2532 2644 2504 2616 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="28">Effect per allele on FPG levels and <italic>p</italic> values, adjusted for age, sex and BMI, were generated by linear regression</p>
###xml 2644 2771 2616 2743 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="29">Because of differences in the number of participants genotyped for each of the loci, the estimated means are slightly different</p>
###xml 2771 2812 2743 2784 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="30">The B genotype represents the risk allele</p>
###xml 2812 2988 2784 2960 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="31">Odds ratios are for associations of independent SNPs with type 2 diabetes and were calculated based on allele frequency in 2,041 controls and 2,628 type 2 diabetes participants</p>
###xml 2988 3045 2960 3017 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="32">Subjects with IGT or IFG were excluded from this analysis</p>
###xml 3045 3065 3017 3037 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="33">T2D, type 2 diabetes</p>
###xml 2451 3065 2425 3037 <table-wrap-foot xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="27">Estimated FPG levels (mean&#8201;&#177;&#8201;SD) per genotype are adjusted for age, sex and BMI</p><p textid="28">Effect per allele on FPG levels and <italic>p</italic> values, adjusted for age, sex and BMI, were generated by linear regression</p><p textid="29">Because of differences in the number of participants genotyped for each of the loci, the estimated means are slightly different</p><p textid="30">The B genotype represents the risk allele</p><p textid="31">Odds ratios are for associations of independent SNPs with type 2 diabetes and were calculated based on allele frequency in 2,041 controls and 2,628 type 2 diabetes participants</p><p textid="32">Subjects with IGT or IFG were excluded from this analysis</p><p textid="33">T2D, type 2 diabetes</p></table-wrap-foot>
###xml 1790 3065 1788 3037 <table-wrap xmlns:xlink="http://www.w3.org/1999/xlink" id="Tab1"><label>Table&#160;1</label><caption><p textid="26">Association of SNPs with FPG (<italic>n</italic>&#8201;=&#8201;2,361) and type 2 diabetes (<italic>n</italic>&#8201;=&#8201;4,669)</p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="2">SNP</th><th rowspan="2">Locus</th><th rowspan="2">Risk allele</th><th colspan="3">FPG, mmol/l (genotype count)</th><th rowspan="2">Effect per allele, mmol/l (95% CI)</th><th rowspan="2"><italic>p</italic> value</th><th>T2D OR</th><th rowspan="2"><italic>p</italic> value</th></tr><tr><th>AA</th><th>AB</th><th>BB</th><th>95% CI</th></tr></thead><tbody><tr><td>rs1799884</td><td><italic>GCK</italic></td><td>A</td><td char="(" align="char">5.39&#8201;&#177;&#8201;0.01 (1,523)</td><td char="(" align="char">5.45&#8201;&#177;&#8201;0.02 (620)</td><td char="(" align="char">5.47&#8201;&#177;&#8201;0.05 (65)</td><td>0.06 (0.03, 0.09)</td><td>0.001</td><td>1.12 (1.00, 1.25)</td><td char="." align="char">0.06</td></tr><tr><td>rs1260326</td><td><italic>GCKR</italic></td><td>C</td><td char="(" align="char">5.35&#8201;&#177;&#8201;0.03 (267)</td><td char="(" align="char">5.39&#8201;&#177;&#8201;0.01 (956)</td><td char="(" align="char">5.38&#8201;&#177;&#8201;0.01 (924)</td><td>0.01 (&#8722;0.02, 0.03)</td><td>0.23</td><td>0.94 (0.86, 1.02)</td><td char="." align="char">0.13</td></tr><tr><td>rs560887</td><td><italic>G6PC2</italic></td><td>G</td><td char="(" align="char">5.32&#8201;&#177;&#8201;0.03 (218)</td><td char="(" align="char">5.36&#8201;&#177;&#8201;0.01 (930)</td><td char="(" align="char">5.43&#8201;&#177;&#8201;0.01 (1,077)</td><td>0.06 (0.04, 0.09)</td><td>5&#8201;&#215;&#8201;10<sup>&#8722;6</sup></td><td>0.96 (0.87, 1.05)</td><td char="." align="char">0.32</td></tr><tr><td>rs10830963</td><td><italic>MTNR1B</italic></td><td>G</td><td char="(" align="char">5.37&#8201;&#177;&#8201;0.01 (1,269)</td><td char="(" align="char">5.44&#8201;&#177;&#8201;0.01 (891)</td><td char="(" align="char">5.52&#8201;&#177;&#8201;0.04 (135)</td><td>0.08 (0.05, 0.11)</td><td>7&#8201;&#215;&#8201;10<sup>&#8722;8</sup></td><td>1.12 (1.02, 1.23)</td><td char="." align="char">0.02</td></tr></tbody></table><table-wrap-foot><p textid="27">Estimated FPG levels (mean&#8201;&#177;&#8201;SD) per genotype are adjusted for age, sex and BMI</p><p textid="28">Effect per allele on FPG levels and <italic>p</italic> values, adjusted for age, sex and BMI, were generated by linear regression</p><p textid="29">Because of differences in the number of participants genotyped for each of the loci, the estimated means are slightly different</p><p textid="30">The B genotype represents the risk allele</p><p textid="31">Odds ratios are for associations of independent SNPs with type 2 diabetes and were calculated based on allele frequency in 2,041 controls and 2,628 type 2 diabetes participants</p><p textid="32">Subjects with IGT or IFG were excluded from this analysis</p><p textid="33">T2D, type 2 diabetes</p></table-wrap-foot></table-wrap>
###xml 3065 3071 3037 3043 <label xmlns:xlink="http://www.w3.org/1999/xlink">Fig.&#160;1</label>
###xml 3090 3093 3062 3065 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GCK</italic>
###xml 3095 3099 3067 3071 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GCKR</italic>
###xml 3101 3106 3073 3078 <italic xmlns:xlink="http://www.w3.org/1999/xlink">G6PC2</italic>
###xml 3111 3117 3083 3089 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MTNR1B</italic>
###xml 3132 3134 3104 3106 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1c</sub>
###xml 3190 3191 3162 3163 <bold xmlns:xlink="http://www.w3.org/1999/xlink">a</bold>
###xml 3338 3339 3310 3311 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 3348 3351 3320 3323 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;13</sup>
###xml 3383 3384 3355 3356 <bold xmlns:xlink="http://www.w3.org/1999/xlink">b</bold>
###xml 3388 3390 3360 3362 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1c</sub>
###xml 3517 3518 3489 3490 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 3527 3530 3499 3502 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;10</sup>
###xml 3071 3558 3043 3530 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="34">Combined effect of <italic>GCK</italic>, <italic>GCKR</italic>, <italic>G6PC2</italic> and <italic>MTNR1B</italic> on FPG and HbA<sub>1c</sub> in non-diabetic participants from the New Hoorn Study. <bold>a</bold> Fasting plasma glucose. Numbers within the bars are numbers of participants per allele group. The per allele effect was 0.05 (0.04&#8211;0.07)&#8201; mmol/l, <italic>p</italic>&#8201;=&#8201;2&#8201;&#215;&#8201;10<sup>&#8722;13</sup>). Error bars represent 95% CI. <bold>b</bold> HbA<sub>1c</sub>. Numbers within the bars represent the number of participants per allele group. The per allele effect was 0.03% (0.02&#8211;0.04%), <italic>p</italic>&#8201;=&#8201;5&#8201;&#215;&#8201;10<sup>&#8722;10</sup> Error bars represent 95% CI</p>
###xml 3071 3558 3043 3530 <caption xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="34">Combined effect of <italic>GCK</italic>, <italic>GCKR</italic>, <italic>G6PC2</italic> and <italic>MTNR1B</italic> on FPG and HbA<sub>1c</sub> in non-diabetic participants from the New Hoorn Study. <bold>a</bold> Fasting plasma glucose. Numbers within the bars are numbers of participants per allele group. The per allele effect was 0.05 (0.04&#8211;0.07)&#8201; mmol/l, <italic>p</italic>&#8201;=&#8201;2&#8201;&#215;&#8201;10<sup>&#8722;13</sup>). Error bars represent 95% CI. <bold>b</bold> HbA<sub>1c</sub>. Numbers within the bars represent the number of participants per allele group. The per allele effect was 0.03% (0.02&#8211;0.04%), <italic>p</italic>&#8201;=&#8201;5&#8201;&#215;&#8201;10<sup>&#8722;10</sup> Error bars represent 95% CI</p></caption>
###xml 3558 3558 3530 3530 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="anchor" xlink:href="125_2009_1413_Fig1_HTML" id="MO1"/>
###xml 3065 3558 3037 3530 <fig xmlns:xlink="http://www.w3.org/1999/xlink" id="Fig1"><label>Fig.&#160;1</label><caption><p textid="34">Combined effect of <italic>GCK</italic>, <italic>GCKR</italic>, <italic>G6PC2</italic> and <italic>MTNR1B</italic> on FPG and HbA<sub>1c</sub> in non-diabetic participants from the New Hoorn Study. <bold>a</bold> Fasting plasma glucose. Numbers within the bars are numbers of participants per allele group. The per allele effect was 0.05 (0.04&#8211;0.07)&#8201; mmol/l, <italic>p</italic>&#8201;=&#8201;2&#8201;&#215;&#8201;10<sup>&#8722;13</sup>). Error bars represent 95% CI. <bold>b</bold> HbA<sub>1c</sub>. Numbers within the bars represent the number of participants per allele group. The per allele effect was 0.03% (0.02&#8211;0.04%), <italic>p</italic>&#8201;=&#8201;5&#8201;&#215;&#8201;10<sup>&#8722;10</sup> Error bars represent 95% CI</p></caption><graphic position="anchor" xlink:href="125_2009_1413_Fig1_HTML" id="MO1"/></fig>
###xml 127 139 <span type="species:ncbi:9606">participants</span>
###xml 1684 1696 <span type="species:ncbi:9606">participants</span>
###xml 2684 2696 <span type="species:ncbi:9606">participants</span>
###xml 3151 3163 <span type="species:ncbi:9606">participants</span>
###xml 3255 3267 <span type="species:ncbi:9606">participants</span>
###xml 3440 3452 <span type="species:ncbi:9606">participants</span>
All SNPs passed quality control guidelines. Associations between SNPs and clinical variables were analysed in the non-diabetic participants only. Results of association with FPG levels were comparable to those reported in the literature (all p </= 0.001), except for GCKR, for which we could not detect a significant effect on FPG levels (p = 0.23; results shown in Table 1). However, GCKR showed nominal evidence for decreased 2 h glucose, but did not reach a formally significant p value (p = 0.008; see Electronic supplementary material [ESM] Table 1). Furthermore, GCK and G6PC2 showed increased HbA1c levels (p = 5 x 10-8 and 3 x 10-5; ESM Table 1). In line with our FPG results, GCKR was not associated with HbA1c levels (p = 0.50). However, we did confirm the previously reported association of the T allele of rs1260326 (GCKR) with increased triacylglycerol levels (p = 9 x 10-7; ESM Table 1) [5]. Other clinical variables were not associated with any of the analysed variants (ESM Table 1). We analysed the combined effect of all SNPs by calculating the risk allele score for each individual. We observed a combined effect of the risk alleles on FPG levels. The increase in FPG level per additional risk allele was 0.05 (0.04-0.07) mmol/l, p = 2 x 10-13 (Fig. 1a). A similar result was observed for HbA1c: 0.03% (0.02-0.04%) increase per additional risk allele, p = 5 x 10-10 (Fig. 1b). We also analysed whether the rate of the age-related increase in FPG was affected by the number of risk alleles. However, we did not observe any divergence in these rates between the different risk allele scores in our cross-sectional data set (ESM Fig. 1). Separate analysis of only the participants with normal glucose tolerance (n = 2,041) did not alter any of the results (data not shown). Table 1Association of SNPs with FPG (n = 2,361) and type 2 diabetes (n = 4,669)SNPLocusRisk alleleFPG, mmol/l (genotype count)Effect per allele, mmol/l (95% CI)p valueT2D ORp valueAAABBB95% CIrs1799884GCKA5.39 +/- 0.01 (1,523)5.45 +/- 0.02 (620)5.47 +/- 0.05 (65)0.06 (0.03, 0.09)0.0011.12 (1.00, 1.25)0.06rs1260326GCKRC5.35 +/- 0.03 (267)5.39 +/- 0.01 (956)5.38 +/- 0.01 (924)0.01 (-0.02, 0.03)0.230.94 (0.86, 1.02)0.13rs560887G6PC2G5.32 +/- 0.03 (218)5.36 +/- 0.01 (930)5.43 +/- 0.01 (1,077)0.06 (0.04, 0.09)5 x 10-60.96 (0.87, 1.05)0.32rs10830963MTNR1BG5.37 +/- 0.01 (1,269)5.44 +/- 0.01 (891)5.52 +/- 0.04 (135)0.08 (0.05, 0.11)7 x 10-81.12 (1.02, 1.23)0.02Estimated FPG levels (mean +/- SD) per genotype are adjusted for age, sex and BMIEffect per allele on FPG levels and p values, adjusted for age, sex and BMI, were generated by linear regressionBecause of differences in the number of participants genotyped for each of the loci, the estimated means are slightly differentThe B genotype represents the risk alleleOdds ratios are for associations of independent SNPs with type 2 diabetes and were calculated based on allele frequency in 2,041 controls and 2,628 type 2 diabetes participantsSubjects with IGT or IFG were excluded from this analysisT2D, type 2 diabetesFig. 1Combined effect of GCK, GCKR, G6PC2 and MTNR1B on FPG and HbA1c in non-diabetic participants from the New Hoorn Study. a Fasting plasma glucose. Numbers within the bars are numbers of participants per allele group. The per allele effect was 0.05 (0.04-0.07)  mmol/l, p = 2 x 10-13). Error bars represent 95% CI. b HbA1c. Numbers within the bars represent the number of participants per allele group. The per allele effect was 0.03% (0.02-0.04%), p = 5 x 10-10 Error bars represent 95% CI
###end p 25
###begin p 26
###xml 30 31 30 31 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 62 63 62 63 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
Association of SNPs with FPG (n = 2,361) and type 2 diabetes (n = 4,669)
###end p 26
###begin p 27
Estimated FPG levels (mean +/- SD) per genotype are adjusted for age, sex and BMI
###end p 27
###begin p 28
###xml 36 37 36 37 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
Effect per allele on FPG levels and p values, adjusted for age, sex and BMI, were generated by linear regression
###end p 28
###begin p 29
###xml 40 52 <span type="species:ncbi:9606">participants</span>
Because of differences in the number of participants genotyped for each of the loci, the estimated means are slightly different
###end p 29
###begin p 30
The B genotype represents the risk allele
###end p 30
###begin p 31
###xml 164 176 <span type="species:ncbi:9606">participants</span>
Odds ratios are for associations of independent SNPs with type 2 diabetes and were calculated based on allele frequency in 2,041 controls and 2,628 type 2 diabetes participants
###end p 31
###begin p 32
Subjects with IGT or IFG were excluded from this analysis
###end p 32
###begin p 33
T2D, type 2 diabetes
###end p 33
###begin p 34
###xml 19 22 19 22 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GCK</italic>
###xml 24 28 24 28 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GCKR</italic>
###xml 30 35 30 35 <italic xmlns:xlink="http://www.w3.org/1999/xlink">G6PC2</italic>
###xml 40 46 40 46 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MTNR1B</italic>
###xml 61 63 61 63 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1c</sub>
###xml 119 120 119 120 <bold xmlns:xlink="http://www.w3.org/1999/xlink">a</bold>
###xml 267 268 267 268 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 277 280 277 280 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;13</sup>
###xml 312 313 312 313 <bold xmlns:xlink="http://www.w3.org/1999/xlink">b</bold>
###xml 317 319 317 319 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1c</sub>
###xml 446 447 446 447 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 456 459 456 459 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;10</sup>
###xml 80 92 <span type="species:ncbi:9606">participants</span>
###xml 184 196 <span type="species:ncbi:9606">participants</span>
###xml 369 381 <span type="species:ncbi:9606">participants</span>
Combined effect of GCK, GCKR, G6PC2 and MTNR1B on FPG and HbA1c in non-diabetic participants from the New Hoorn Study. a Fasting plasma glucose. Numbers within the bars are numbers of participants per allele group. The per allele effect was 0.05 (0.04-0.07)  mmol/l, p = 2 x 10-13). Error bars represent 95% CI. b HbA1c. Numbers within the bars represent the number of participants per allele group. The per allele effect was 0.03% (0.02-0.04%), p = 5 x 10-10 Error bars represent 95% CI
###end p 34
###begin p 35
###xml 142 148 142 148 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MTNR1B</italic>
###xml 165 168 165 168 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GCK</italic>
###xml 229 230 229 230 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 242 243 242 243 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 271 272 271 272 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Tab1" ref-type="table">1</xref>
###xml 287 288 287 288 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="MOESM2">2</xref>
###xml 733 734 733 734 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Tab2" ref-type="table">2</xref>
###xml 852 853 852 853 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 1007 1008 1007 1008 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 1017 1019 1017 1019 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;6</sup>
###xml 1081 1088 1081 1088 <label xmlns:xlink="http://www.w3.org/1999/xlink">Table&#160;2</label>
###xml 1088 1142 1088 1142 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="36">Association of risk allele scores with type 2 diabetes</p>
###xml 1088 1142 1088 1142 <caption xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="36">Association of risk allele scores with type 2 diabetes</p></caption>
###xml 1142 1149 1142 1149 <th xmlns:xlink="http://www.w3.org/1999/xlink" rowspan="2">Alleles</th>
###xml 1149 1166 1149 1166 <th xmlns:xlink="http://www.w3.org/1999/xlink" colspan="2">Count (frequency)</th>
###xml 1182 1183 1182 1183 <sup xmlns:xlink="http://www.w3.org/1999/xlink">a</sup>
###xml 1166 1204 1166 1202 <th xmlns:xlink="http://www.w3.org/1999/xlink" rowspan="2">Age at diagnosis<sup>a</sup> (years, mean&#8201;&#177;&#8201;SD)</th>
###xml 1204 1223 1202 1221 <th xmlns:xlink="http://www.w3.org/1999/xlink" rowspan="2">OR for T2D (95% CI)</th>
###xml 1223 1224 1221 1222 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 1223 1241 1221 1239 <th xmlns:xlink="http://www.w3.org/1999/xlink" rowspan="2"><italic>p</italic> value OR for T2D</th>
###xml 1142 1241 1142 1239 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><th rowspan="2">Alleles</th><th colspan="2">Count (frequency)</th><th rowspan="2">Age at diagnosis<sup>a</sup> (years, mean&#8201;&#177;&#8201;SD)</th><th rowspan="2">OR for T2D (95% CI)</th><th rowspan="2"><italic>p</italic> value OR for T2D</th></tr>
###xml 1251 1252 1249 1250 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 1241 1261 1239 1259 <th xmlns:xlink="http://www.w3.org/1999/xlink">Controls (<italic>n</italic>&#8201;=&#8201;2,041)</th>
###xml 1268 1269 1266 1267 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 1261 1278 1259 1276 <th xmlns:xlink="http://www.w3.org/1999/xlink">Cases (<italic>n</italic>&#8201;=&#8201;2,628)</th>
###xml 1241 1278 1239 1276 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><th>Controls (<italic>n</italic>&#8201;=&#8201;2,041)</th><th>Cases (<italic>n</italic>&#8201;=&#8201;2,628)</th></tr>
###xml 1142 1278 1142 1276 <thead xmlns:xlink="http://www.w3.org/1999/xlink"><tr><th rowspan="2">Alleles</th><th colspan="2">Count (frequency)</th><th rowspan="2">Age at diagnosis<sup>a</sup> (years, mean&#8201;&#177;&#8201;SD)</th><th rowspan="2">OR for T2D (95% CI)</th><th rowspan="2"><italic>p</italic> value OR for T2D</th></tr><tr><th>Controls (<italic>n</italic>&#8201;=&#8201;2,041)</th><th>Cases (<italic>n</italic>&#8201;=&#8201;2,628)</th></tr></thead>
###xml 1278 1284 1276 1282 <td xmlns:xlink="http://www.w3.org/1999/xlink">0 or 1</td>
###xml 1284 1292 1282 1290 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">76 (4.2)</td>
###xml 1292 1301 1290 1299 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">115 (4.9)</td>
###xml 1301 1313 1299 1309 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="&#xB1;" align="char">57.5&#8201;&#177;&#8201;1.1</td>
###xml 1313 1329 1309 1325 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="center">0.75 (0.55&#8211;1.02)</td>
###xml 1329 1333 1325 1329 <td xmlns:xlink="http://www.w3.org/1999/xlink">0.07</td>
###xml 1278 1333 1276 1329 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td>0 or 1</td><td char="(" align="char">76 (4.2)</td><td char="(" align="char">115 (4.9)</td><td char="&#177;" align="char">57.5&#8201;&#177;&#8201;1.1</td><td align="center">0.75 (0.55&#8211;1.02)</td><td>0.07</td></tr>
###xml 1333 1334 1329 1330 <td xmlns:xlink="http://www.w3.org/1999/xlink">2</td>
###xml 1334 1344 1330 1340 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">243 (13.5)</td>
###xml 1344 1354 1340 1350 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">352 (15.0)</td>
###xml 1354 1366 1350 1360 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="&#xB1;" align="char">57.3&#8201;&#177;&#8201;0.6</td>
###xml 1366 1382 1360 1376 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="center">0.78 (0.64&#8211;0.95)</td>
###xml 1382 1386 1376 1380 <td xmlns:xlink="http://www.w3.org/1999/xlink">0.02</td>
###xml 1333 1386 1329 1380 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td>2</td><td char="(" align="char">243 (13.5)</td><td char="(" align="char">352 (15.0)</td><td char="&#177;" align="char">57.3&#8201;&#177;&#8201;0.6</td><td align="center">0.78 (0.64&#8211;0.95)</td><td>0.02</td></tr>
###xml 1386 1387 1380 1381 <td xmlns:xlink="http://www.w3.org/1999/xlink">3</td>
###xml 1387 1397 1381 1391 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">522 (29.0)</td>
###xml 1397 1407 1391 1401 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">667 (28.4)</td>
###xml 1407 1419 1401 1411 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="&#xB1;" align="char">56.1&#8201;&#177;&#8201;0.5</td>
###xml 1419 1435 1411 1427 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">0.89 (0.76&#8211;1.04)</td>
###xml 1435 1439 1427 1431 <td xmlns:xlink="http://www.w3.org/1999/xlink">0.14</td>
###xml 1386 1439 1380 1431 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td>3</td><td char="(" align="char">522 (29.0)</td><td char="(" align="char">667 (28.4)</td><td char="&#177;" align="char">56.1&#8201;&#177;&#8201;0.5</td><td char="(" align="char">0.89 (0.76&#8211;1.04)</td><td>0.14</td></tr>
###xml 1439 1440 1431 1432 <td xmlns:xlink="http://www.w3.org/1999/xlink">4</td>
###xml 1440 1450 1432 1442 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">605 (33.6)</td>
###xml 1450 1460 1442 1452 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">685 (29.1)</td>
###xml 1460 1472 1452 1462 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="&#xB1;" align="char">55.6&#8201;&#177;&#8201;0.4</td>
###xml 1472 1476 1462 1466 <td xmlns:xlink="http://www.w3.org/1999/xlink">1.00</td>
###xml 1476 1479 1466 1469 <td xmlns:xlink="http://www.w3.org/1999/xlink">ref</td>
###xml 1439 1479 1431 1469 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td>4</td><td char="(" align="char">605 (33.6)</td><td char="(" align="char">685 (29.1)</td><td char="&#177;" align="char">55.6&#8201;&#177;&#8201;0.4</td><td>1.00</td><td>ref</td></tr>
###xml 1479 1480 1469 1470 <td xmlns:xlink="http://www.w3.org/1999/xlink">5</td>
###xml 1480 1490 1470 1480 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">288 (16.0)</td>
###xml 1490 1500 1480 1490 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">381 (16.2)</td>
###xml 1500 1512 1490 1500 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="&#xB1;" align="char">56.1&#8201;&#177;&#8201;0.6</td>
###xml 1512 1528 1500 1516 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">1.17 (0.97&#8211;1.41)</td>
###xml 1528 1532 1516 1520 <td xmlns:xlink="http://www.w3.org/1999/xlink">0.11</td>
###xml 1479 1532 1469 1520 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td>5</td><td char="(" align="char">288 (16.0)</td><td char="(" align="char">381 (16.2)</td><td char="&#177;" align="char">56.1&#8201;&#177;&#8201;0.6</td><td char="(" align="char">1.17 (0.97&#8211;1.41)</td><td>0.11</td></tr>
###xml 1532 1535 1520 1523 <td xmlns:xlink="http://www.w3.org/1999/xlink">6&#8211;8</td>
###xml 1535 1543 1523 1531 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">65 (3.6)</td>
###xml 1543 1552 1531 1540 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">151 (6.4)</td>
###xml 1552 1564 1540 1550 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="&#xB1;" align="char">52.9&#8201;&#177;&#8201;0.9</td>
###xml 1564 1580 1550 1566 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">2.05 (1.50&#8211;2.80)</td>
###xml 1586 1588 1572 1574 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;6</sup>
###xml 1580 1588 1566 1574 <td xmlns:xlink="http://www.w3.org/1999/xlink">4&#8201;&#215;&#8201;10<sup>&#8722;6</sup></td>
###xml 1532 1588 1520 1574 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td>6&#8211;8</td><td char="(" align="char">65 (3.6)</td><td char="(" align="char">151 (6.4)</td><td char="&#177;" align="char">52.9&#8201;&#177;&#8201;0.9</td><td char="(" align="char">2.05 (1.50&#8211;2.80)</td><td>4&#8201;&#215;&#8201;10<sup>&#8722;6</sup></td></tr>
###xml 1278 1588 1276 1574 <tbody xmlns:xlink="http://www.w3.org/1999/xlink"><tr><td>0 or 1</td><td char="(" align="char">76 (4.2)</td><td char="(" align="char">115 (4.9)</td><td char="&#177;" align="char">57.5&#8201;&#177;&#8201;1.1</td><td align="center">0.75 (0.55&#8211;1.02)</td><td>0.07</td></tr><tr><td>2</td><td char="(" align="char">243 (13.5)</td><td char="(" align="char">352 (15.0)</td><td char="&#177;" align="char">57.3&#8201;&#177;&#8201;0.6</td><td align="center">0.78 (0.64&#8211;0.95)</td><td>0.02</td></tr><tr><td>3</td><td char="(" align="char">522 (29.0)</td><td char="(" align="char">667 (28.4)</td><td char="&#177;" align="char">56.1&#8201;&#177;&#8201;0.5</td><td char="(" align="char">0.89 (0.76&#8211;1.04)</td><td>0.14</td></tr><tr><td>4</td><td char="(" align="char">605 (33.6)</td><td char="(" align="char">685 (29.1)</td><td char="&#177;" align="char">55.6&#8201;&#177;&#8201;0.4</td><td>1.00</td><td>ref</td></tr><tr><td>5</td><td char="(" align="char">288 (16.0)</td><td char="(" align="char">381 (16.2)</td><td char="&#177;" align="char">56.1&#8201;&#177;&#8201;0.6</td><td char="(" align="char">1.17 (0.97&#8211;1.41)</td><td>0.11</td></tr><tr><td>6&#8211;8</td><td char="(" align="char">65 (3.6)</td><td char="(" align="char">151 (6.4)</td><td char="&#177;" align="char">52.9&#8201;&#177;&#8201;0.9</td><td char="(" align="char">2.05 (1.50&#8211;2.80)</td><td>4&#8201;&#215;&#8201;10<sup>&#8722;6</sup></td></tr></tbody>
###xml 1142 1588 1142 1574 <table xmlns:xlink="http://www.w3.org/1999/xlink" frame="hsides" rules="groups"><thead><tr><th rowspan="2">Alleles</th><th colspan="2">Count (frequency)</th><th rowspan="2">Age at diagnosis<sup>a</sup> (years, mean&#8201;&#177;&#8201;SD)</th><th rowspan="2">OR for T2D (95% CI)</th><th rowspan="2"><italic>p</italic> value OR for T2D</th></tr><tr><th>Controls (<italic>n</italic>&#8201;=&#8201;2,041)</th><th>Cases (<italic>n</italic>&#8201;=&#8201;2,628)</th></tr></thead><tbody><tr><td>0 or 1</td><td char="(" align="char">76 (4.2)</td><td char="(" align="char">115 (4.9)</td><td char="&#177;" align="char">57.5&#8201;&#177;&#8201;1.1</td><td align="center">0.75 (0.55&#8211;1.02)</td><td>0.07</td></tr><tr><td>2</td><td char="(" align="char">243 (13.5)</td><td char="(" align="char">352 (15.0)</td><td char="&#177;" align="char">57.3&#8201;&#177;&#8201;0.6</td><td align="center">0.78 (0.64&#8211;0.95)</td><td>0.02</td></tr><tr><td>3</td><td char="(" align="char">522 (29.0)</td><td char="(" align="char">667 (28.4)</td><td char="&#177;" align="char">56.1&#8201;&#177;&#8201;0.5</td><td char="(" align="char">0.89 (0.76&#8211;1.04)</td><td>0.14</td></tr><tr><td>4</td><td char="(" align="char">605 (33.6)</td><td char="(" align="char">685 (29.1)</td><td char="&#177;" align="char">55.6&#8201;&#177;&#8201;0.4</td><td>1.00</td><td>ref</td></tr><tr><td>5</td><td char="(" align="char">288 (16.0)</td><td char="(" align="char">381 (16.2)</td><td char="&#177;" align="char">56.1&#8201;&#177;&#8201;0.6</td><td char="(" align="char">1.17 (0.97&#8211;1.41)</td><td>0.11</td></tr><tr><td>6&#8211;8</td><td char="(" align="char">65 (3.6)</td><td char="(" align="char">151 (6.4)</td><td char="&#177;" align="char">52.9&#8201;&#177;&#8201;0.9</td><td char="(" align="char">2.05 (1.50&#8211;2.80)</td><td>4&#8201;&#215;&#8201;10<sup>&#8722;6</sup></td></tr></tbody></table>
###xml 1588 1589 1574 1575 <sup xmlns:xlink="http://www.w3.org/1999/xlink">a</sup>
###xml 1588 1663 1574 1649 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="37"><sup>a</sup>Age at diagnosis was available for 2,132 participants with type 2 diabetes</p>
###xml 1663 1667 1649 1650 <italic xmlns:xlink="http://www.w3.org/1999/xlink">&#946;</italic>
###xml 1667 1683 1650 1666 <sub xmlns:xlink="http://www.w3.org/1999/xlink">age at diagnosis</sub>
###xml 1716 1717 1699 1700 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 1663 1742 1649 1725 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="38"><italic>&#946;</italic><sub>age at diagnosis</sub>&#8201;=&#8201;&#8722;0.46 (&#8722;0.80 to &#8722;0.11) years, <italic>p</italic>&#8201;=&#8201;0.009 adjusted for sex</p>
###xml 1773 1774 1756 1757 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 1742 1848 1725 1831 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="39">The OR for type 2 diabetes and <italic>p</italic> value were compared with the four risk alleles group as a reference (ref)</p>
###xml 1938 1939 1921 1922 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 2041 2042 2024 2025 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 1848 2050 1831 2033 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="40">The OR for type 2 diabetes for less than three vs four risk alleles was 0.77 (0.65&#8211;0.93), <italic>p</italic>&#8201;=&#8201;0.005 and the OR for type 2 diabetes for more than four vs four risk alleles was 1.33 (1.12&#8211;1.58), <italic>p</italic>&#8201;=&#8201;0.001</p>
###xml 2050 2070 2033 2053 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="41">T2D, type 2 diabetes</p>
###xml 1588 2070 1574 2053 <table-wrap-foot xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="37"><sup>a</sup>Age at diagnosis was available for 2,132 participants with type 2 diabetes</p><p textid="38"><italic>&#946;</italic><sub>age at diagnosis</sub>&#8201;=&#8201;&#8722;0.46 (&#8722;0.80 to &#8722;0.11) years, <italic>p</italic>&#8201;=&#8201;0.009 adjusted for sex</p><p textid="39">The OR for type 2 diabetes and <italic>p</italic> value were compared with the four risk alleles group as a reference (ref)</p><p textid="40">The OR for type 2 diabetes for less than three vs four risk alleles was 0.77 (0.65&#8211;0.93), <italic>p</italic>&#8201;=&#8201;0.005 and the OR for type 2 diabetes for more than four vs four risk alleles was 1.33 (1.12&#8211;1.58), <italic>p</italic>&#8201;=&#8201;0.001</p><p textid="41">T2D, type 2 diabetes</p></table-wrap-foot>
###xml 1081 2070 1081 2053 <table-wrap xmlns:xlink="http://www.w3.org/1999/xlink" id="Tab2"><label>Table&#160;2</label><caption><p textid="36">Association of risk allele scores with type 2 diabetes</p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="2">Alleles</th><th colspan="2">Count (frequency)</th><th rowspan="2">Age at diagnosis<sup>a</sup> (years, mean&#8201;&#177;&#8201;SD)</th><th rowspan="2">OR for T2D (95% CI)</th><th rowspan="2"><italic>p</italic> value OR for T2D</th></tr><tr><th>Controls (<italic>n</italic>&#8201;=&#8201;2,041)</th><th>Cases (<italic>n</italic>&#8201;=&#8201;2,628)</th></tr></thead><tbody><tr><td>0 or 1</td><td char="(" align="char">76 (4.2)</td><td char="(" align="char">115 (4.9)</td><td char="&#177;" align="char">57.5&#8201;&#177;&#8201;1.1</td><td align="center">0.75 (0.55&#8211;1.02)</td><td>0.07</td></tr><tr><td>2</td><td char="(" align="char">243 (13.5)</td><td char="(" align="char">352 (15.0)</td><td char="&#177;" align="char">57.3&#8201;&#177;&#8201;0.6</td><td align="center">0.78 (0.64&#8211;0.95)</td><td>0.02</td></tr><tr><td>3</td><td char="(" align="char">522 (29.0)</td><td char="(" align="char">667 (28.4)</td><td char="&#177;" align="char">56.1&#8201;&#177;&#8201;0.5</td><td char="(" align="char">0.89 (0.76&#8211;1.04)</td><td>0.14</td></tr><tr><td>4</td><td char="(" align="char">605 (33.6)</td><td char="(" align="char">685 (29.1)</td><td char="&#177;" align="char">55.6&#8201;&#177;&#8201;0.4</td><td>1.00</td><td>ref</td></tr><tr><td>5</td><td char="(" align="char">288 (16.0)</td><td char="(" align="char">381 (16.2)</td><td char="&#177;" align="char">56.1&#8201;&#177;&#8201;0.6</td><td char="(" align="char">1.17 (0.97&#8211;1.41)</td><td>0.11</td></tr><tr><td>6&#8211;8</td><td char="(" align="char">65 (3.6)</td><td char="(" align="char">151 (6.4)</td><td char="&#177;" align="char">52.9&#8201;&#177;&#8201;0.9</td><td char="(" align="char">2.05 (1.50&#8211;2.80)</td><td>4&#8201;&#215;&#8201;10<sup>&#8722;6</sup></td></tr></tbody></table><table-wrap-foot><p textid="37"><sup>a</sup>Age at diagnosis was available for 2,132 participants with type 2 diabetes</p><p textid="38"><italic>&#946;</italic><sub>age at diagnosis</sub>&#8201;=&#8201;&#8722;0.46 (&#8722;0.80 to &#8722;0.11) years, <italic>p</italic>&#8201;=&#8201;0.009 adjusted for sex</p><p textid="39">The OR for type 2 diabetes and <italic>p</italic> value were compared with the four risk alleles group as a reference (ref)</p><p textid="40">The OR for type 2 diabetes for less than three vs four risk alleles was 0.77 (0.65&#8211;0.93), <italic>p</italic>&#8201;=&#8201;0.005 and the OR for type 2 diabetes for more than four vs four risk alleles was 1.33 (1.12&#8211;1.58), <italic>p</italic>&#8201;=&#8201;0.001</p><p textid="41">T2D, type 2 diabetes</p></table-wrap-foot></table-wrap>
###xml 334 346 <span type="species:ncbi:9606">participants</span>
###xml 1630 1642 <span type="species:ncbi:9606">participants</span>
Next, we analysed the association of the single gene variants and the risk allele score with type 2 diabetes susceptibility. Only rs10830963 (MTNR1B) and rs1799884 (GCK) showed weak evidence for association with type 2 diabetes (p = 0.02 and p = 0.06 respectively; Table 1 and ESM Table 2). Risk allele scores were calculated for the participants with normal glucose tolerance and those with type 2 diabetes and all risk allele groups were compared with the reference group having four risk alleles, since this was the most common group (31%). The lower risk allele groups showed a protective effect on type 2 diabetes, while the risk allele groups with more than four risk alleles showed an increased risk of type 2 diabetes (Table 2). Those with fewer than three risk alleles had a significantly reduced risk of type 2 diabetes (OR 0.77 [0.65-0.93], p = 0.005) whereas those with more than five had a significantly increased risk of type 2 diabetes compared with the reference group (OR 2.05 [1.50-2.80], p = 4 x 10-6). Adjustment for age, sex and BMI did not alter the results. Table 2Association of risk allele scores with type 2 diabetesAllelesCount (frequency)Age at diagnosisa (years, mean +/- SD)OR for T2D (95% CI)p value OR for T2DControls (n = 2,041)Cases (n = 2,628)0 or 176 (4.2)115 (4.9)57.5 +/- 1.10.75 (0.55-1.02)0.072243 (13.5)352 (15.0)57.3 +/- 0.60.78 (0.64-0.95)0.023522 (29.0)667 (28.4)56.1 +/- 0.50.89 (0.76-1.04)0.144605 (33.6)685 (29.1)55.6 +/- 0.41.00ref5288 (16.0)381 (16.2)56.1 +/- 0.61.17 (0.97-1.41)0.116-865 (3.6)151 (6.4)52.9 +/- 0.92.05 (1.50-2.80)4 x 10-6aAge at diagnosis was available for 2,132 participants with type 2 diabetesbetaage at diagnosis = -0.46 (-0.80 to -0.11) years, p = 0.009 adjusted for sexThe OR for type 2 diabetes and p value were compared with the four risk alleles group as a reference (ref)The OR for type 2 diabetes for less than three vs four risk alleles was 0.77 (0.65-0.93), p = 0.005 and the OR for type 2 diabetes for more than four vs four risk alleles was 1.33 (1.12-1.58), p = 0.001T2D, type 2 diabetes
###end p 35
###begin p 36
Association of risk allele scores with type 2 diabetes
###end p 36
###begin p 37
###xml 0 1 0 1 <sup xmlns:xlink="http://www.w3.org/1999/xlink">a</sup>
###xml 42 54 <span type="species:ncbi:9606">participants</span>
aAge at diagnosis was available for 2,132 participants with type 2 diabetes
###end p 37
###begin p 38
###xml 0 4 0 1 <italic xmlns:xlink="http://www.w3.org/1999/xlink">&#946;</italic>
###xml 4 20 1 17 <sub xmlns:xlink="http://www.w3.org/1999/xlink">age at diagnosis</sub>
###xml 53 54 50 51 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
betaage at diagnosis = -0.46 (-0.80 to -0.11) years, p = 0.009 adjusted for sex
###end p 38
###begin p 39
###xml 31 32 31 32 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
The OR for type 2 diabetes and p value were compared with the four risk alleles group as a reference (ref)
###end p 39
###begin p 40
###xml 90 91 90 91 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 193 194 193 194 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
The OR for type 2 diabetes for less than three vs four risk alleles was 0.77 (0.65-0.93), p = 0.005 and the OR for type 2 diabetes for more than four vs four risk alleles was 1.33 (1.12-1.58), p = 0.001
###end p 40
###begin p 41
T2D, type 2 diabetes
###end p 41
###begin p 42
###xml 218 219 218 219 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 235 236 235 236 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Tab2" ref-type="table">2</xref>
###xml 410 411 410 411 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 427 428 427 428 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Tab2" ref-type="table">2</xref>
We also noted a significant correlation with the age at diagnosis of type 2 diabetes in our study sample. We observed a per allele effect of -0.46 (-0.80 to -0.11) years in age at diagnosis per additional risk allele (p = 0.009; Table 2). At the extremes of the distribution, i.e. zero or one vs six to eight risk alleles, there was a difference of almost 4.5 years in age at diagnosis between the two groups (p = 0.002; Table 2).
###end p 42
###begin title 43
Discussion
###end title 43
###begin p 44
###xml 40 43 40 43 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GCK</italic>
###xml 45 49 45 49 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GCKR</italic>
###xml 51 56 51 56 <italic xmlns:xlink="http://www.w3.org/1999/xlink">G6PC2</italic>
###xml 61 67 61 67 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MTNR1B</italic>
###xml 100 101 100 101 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR4">4</xref>
###xml 102 103 102 103 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR7">7</xref>
###xml 105 106 105 106 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR9">9</xref>
###xml 108 110 108 110 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR11">11</xref>
###xml 111 113 111 113 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR13">13</xref>
###xml 115 117 115 117 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR20">20</xref>
###xml 227 231 227 231 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GCKR</italic>
###xml 267 271 267 271 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GCKR</italic>
###xml 464 465 464 465 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR8">8</xref>
###xml 508 510 508 510 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR11">11</xref>
###xml 513 516 513 516 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GCK</italic>
###xml 521 526 521 526 <italic xmlns:xlink="http://www.w3.org/1999/xlink">G6PC2</italic>
###xml 551 553 551 553 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1c</sub>
###xml 606 608 606 608 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR13">13</xref>
###xml 610 612 610 612 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR21">21</xref>
Several studies have shown that SNPs in GCK, GCKR, G6PC2 and MTNR1B are associated with FPG levels [4-7, 9, 11-13, 20]. In this study we replicated these findings in a Dutch population, with the exception of the association of GCKR with FPG. However, our results for GCKR are in the same direction as those of most other studies and it should be noted that some other recent publications reported considerable variability in effect size between different samples [8] or failed to replicate this observation [11]. GCK and G6PC2 were associated with HbA1c in our study, which confirms previous observations [13, 21].
###end p 44
###begin p 45
###xml 127 129 127 129 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR13">13</xref>
###xml 224 226 224 226 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1c</sub>
###xml 311 313 311 313 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1c</sub>
###xml 353 355 353 355 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR22">22</xref>
###xml 357 359 357 359 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR23">23</xref>
We observed a significant combined effect of all variants on FPG levels. This confirms a recent observation in a French study [13]. The association of FPG levels with the risk allele count was also reflected in increased HbA1c levels, arguing against previous findings in which it was suggested that FPG and HbA1c have independent underlying risk loci [22, 23]. Our cross-sectional data suggest that these loci cause a physiological disturbance of glucose homeostasis by raising the set point of insulin secretion, leading to an elevation of FPG depending on the number of risk alleles present, which is not further affected by ageing. However, longitudinal studies and a wider age span would be needed to confirm this observation.
###end p 45
###begin p 46
###xml 251 252 251 252 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Tab1" ref-type="table">1</xref>
To our knowledge, this is the first report showing that the analysed loci have a combined effect on type 2 diabetes susceptibility, although the contribution of each individual variant to the risk of type 2 diabetes is very low or undetectable (Table 1). Our data show that carriers of fewer than three risk alleles are at decreased risk of type 2 diabetes whereas those with more than five risk alleles have increased susceptibility to type 2 diabetes compared with the most common risk allele group of four risk alleles. We also noted a significantly different age at diagnosis between the different groups, indicating that the number of risk alleles also influences the age at which the disease becomes manifest. This might also have implications for the development of complications. If replicated, our results imply that these loci not only influence FPG levels, probably through an altered set point for glucose at which an insulin response is elicited, but also jointly increase the risk of type 2 diabetes and the age at diagnosis.
###end p 46
###begin p 47
###xml 52 55 52 55 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GCK</italic>
###xml 57 61 57 61 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GCKR</italic>
###xml 63 68 63 68 <italic xmlns:xlink="http://www.w3.org/1999/xlink">G6PC2</italic>
###xml 73 79 73 79 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MTNR1B</italic>
###xml 180 182 180 182 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1c</sub>
In conclusion, we replicated the combined effect of GCK, GCKR, G6PC2 and MTNR1B risk alleles with FPG. Furthermore, we showed that the risk allele score is also associated with HbA1c and that carriers of a low or high number of risk alleles have significantly different susceptibilities to the development of type 2 diabetes and age at diagnosis of the disease.
###end p 47
###begin title 48
Electronic supplementary material
###end title 48
###begin p 49
Below is the link to the electronic supplementary material.
###end p 49
###begin p 50
(PDF 21 kb)
###end p 50
###begin p 51
(PDF 11 kb)
###end p 51
###begin p 52
(PDF 30 kb)
###end p 52
###begin title 53
Acknowledgements
###end title 53
###begin p 54
###xml 42 54 <span type="species:ncbi:9606">participants</span>
The authors would like to acknowledge all participants for their cooperation. This project was funded by The Netherlands Organization for Scientific Research, ZonMW RIDE program and the Dutch Diabetes Research Foundation.
###end p 54
###begin p 55
###xml 0 19 0 19 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Duality of interest</bold>
Duality of interest The authors declare that there is no duality of interest associated with this manuscript.
###end p 55
###begin p 56
###xml 0 11 0 11 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Open Access</bold>
Open Access This article is distributed under the terms of the Creative Commons Attribution Noncommercial License which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited.
###end p 56
###begin title 57
References
###end title 57
###begin article-title 58
Hyperglycaemia is associated with all-cause and cardiovascular mortality in the Hoorn population: the Hoorn Study
###end article-title 58
###begin article-title 59
Relation of impaired fasting and postload glucose with incident type 2 diabetes in a Dutch population: The Hoorn Study
###end article-title 59
###begin article-title 60
Bivariate genetic analysis of fasting insulin and glucose levels
###end article-title 60
###begin article-title 61
Genetic regulation of birth weight and fasting glucose by a common polymorphism in the islet cell promoter of the glucokinase gene
###end article-title 61
###begin article-title 62
Genome-wide association analysis identifies loci for type 2 diabetes and triglyceride levels
###end article-title 62
###begin article-title 63
The GCKR rs780094 polymorphism is associated with elevated fasting serum triacylglycerol, reduced fasting and OGTT-related insulinaemia, and reduced risk of type 2 diabetes
###end article-title 63
###begin article-title 64
The common P446L polymorphism in GCKR inversely modulates fasting glucose and triglyceride levels and reduces type 2 diabetes risk in the DESIR prospective general French population
###end article-title 64
###begin article-title 65
Common missense variant in the glucokinase regulatory protein gene is associated with increased plasma triglyceride and C-reactive protein but lower fasting glucose concentrations
###end article-title 65
###begin article-title 66
A polymorphism within the G6PC2 gene is associated with fasting plasma glucose levels
###end article-title 66
###begin article-title 67
###xml 14 30 14 30 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Escherichia coli</italic>
###xml 14 30 <span type="species:ncbi:562">Escherichia coli</span>
CP1 domain in Escherichia coli leucyl-tRNA synthetase is crucial for its editing function
###end article-title 67
###begin article-title 68
Variants in MTNR1B influence fasting glucose levels
###end article-title 68
###begin article-title 69
Common variant in MTNR1B associated with increased risk of type 2 diabetes and impaired early insulin secretion
###end article-title 69
###begin article-title 70
A variant near MTNR1B is associated with increased fasting plasma glucose levels and type 2 diabetes risk
###end article-title 70
###begin article-title 71
Limited agreement between HbA1c and glucose in the general Dutch population: The New Hoorn Study
###end article-title 71
###begin article-title 72
Genetic association analysis of 13 nuclear-encoded mitochondrial candidate genes with type II diabetes mellitus: the DAMAGE Study
###end article-title 72
###begin article-title 73
###xml 23 31 <span type="species:ncbi:9606">patients</span>
###xml 62 69 <span type="species:ncbi:9606">patient</span>
Disease management for patients with type 2 diabetes: towards patient empowerment
###end article-title 73
###begin article-title 74
Combining information from common type 2 diabetes risk polymorphisms improves disease prediction
###end article-title 74
###begin article-title 75
Sample size requirements for association studies of gene-gene interaction
###end article-title 75
###begin article-title 76
Variations in the G6PC2/ABCB11 genomic region are associated with fasting glucose levels
###end article-title 76
###begin article-title 77
###xml 115 127 <span type="species:ncbi:9606">participants</span>
###xml 135 140 <span type="species:ncbi:9606">Women</span>
Novel association of HK1 with glycated hemoglobin in a non-diabetic population: a genome-wide evaluation of 14,618 participants in the Women's Genome Health Study
###end article-title 77
###begin article-title 78
HbA(1c) levels are genetically determined even in type 1 diabetes: evidence from healthy and diabetic twins
###end article-title 78
###begin article-title 79
The heritability of HbA1c and fasting blood glucose in different measurement settings
###end article-title 79
###begin title 80
Abbreviations
###end title 80
###begin p 81
Diabetes Care System West Friesland
###end p 81
###begin p 82
Fasting plasma glucose
###end p 82
###begin p 83
Single-nucleotide polymorphism
###end p 83
###begin p 84
###xml 0 33 0 33 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Electronic supplementary material</bold>
Electronic supplementary material
###end p 84
###begin p 85
The online version of this article (doi:10.1007/s00125-009-1413-9) contains supplementary material, which is available to authorised users.
###end p 85

